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Escherichia coli and many other microorganisms synthesize aromatic amino acids through the condensation
reaction between phosphoenolpyruvate (PEP) and erythrose 4-phosphate to form 3-deoxy-D-arabinoheptu-
losonate 7-phosphate (DAHP). It has been shown that overexpression of transketolase increases the production
of DAHP in an aroB mutant strain (unable to further metabolize DAHP) with elevated DAHP synthase.
However, the yield (percent conversion) of DAHP from glucose is still low. Stoichiometric analysis shows that
many enzymes compete for intracellular PEP. In particular, the phosphotransferase system, responsible for
glucose transport in E. coli, uses PEP as a phosphate donor and converts it to pyruvate, which is less likely to
recycle back to PEP. This stoichiometric limitation greatly reduces the yield of aromatic metabolites. To relieve
this limitation, we overexpressed PEP synthase in the presence of glucose and showed that it increased the final
concentration and the yield of DAHP by almost twofold, to a near theoretical maximum. The PEP synthase
effect is not observed without overproduced transketolase, suggesting that erythrose 4-phosphate is the first
limiting metabolite. This result demonstrates the utility of pathway analysis and the limitation of central
metabolites in the high-level overproduction of desired metabolites.
Production of biochemicals from microorganisms has long
been an important application of biotechnology. Typically, the
steps involved in developing a production strain include (i)
selection of a proper host organism, (ii) elimination of path-
ways leading to by-products, (iii) deregulation of pathways at
both the enzyme activity level and the transcriptional level, and
(iv) overexpression of enzymes in the desired pathways. The
last three steps can now be achieved by a variety of in vivo and
in vitro methods. These processes are particularly user-friendly
in well-studied microorganisms such as Escherichia coli. There-
fore, many articles on the engineering of microorganisms for
physiological characterization (6, 18, 25) and metabolite pro-
duction (2, 3, 12) have been published. In most cases, the first
target for engineering is the terminal pathway leading to the
desired product, and the results are usually successful. How-
ever, further improvement of productivity (product formation
rate) and yield (percent conversion) calls for the alteration of
central metabolic pathways which supply necessary precursors
and energy for biosyntheses.
Aromatic metabolites such as tryptophan, phenylalanine,
and tyrosine are essential amino acids for humans and animals.
In addition, phenylalanine is used in aspartame production
(15, 19), and the tryptophan pathway can be modified to
produce indigo (8). In E. coli, aromatic metabolites are gen-
erated from the condensation reaction between phosphoenol-
pyruvate (PEP) and erythrose 4-phosphate (E4P) to form
3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP). This
step is the first committed step toward synthesis of aromatic
metabolites and is mediated by three DAHP synthases. These
isoenzymes are encoded by the genes aroF, aroG, and aroH,
whose products are feedback inhibited by tyrosine, phenylala-
nine, and tryptophan, respectively. The production of trypto-
phan and phenylalanine by E. coli has been well documented
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(1, 9, 11, 17). As expected, the productivity and yield have
increased as a result of deleting branched pathways, deregu-
lating enzymes, and overexpressing terminal pathways. For
example, Aiba et al. (1) have reported a tryptophan overpro-
ducer that contains overexpressed genes in the tryptophan
operon in a host strain that is trpR and tna (encoding trypto-
phanase) negative. Moreover, various enzymes, such as the
trpE gene product (1), have been mutated to resist feedback
inhibition. Similar work has been reported for phenylalanine
production. In addition to engineering the terminal pathways,
Miller et al. (17) attempted to direct more carbon flux into the
amino acid pathway by use of a PEP carboxylase (coded by
ppc)-deficient mutant. Draths et al. (7) reported that overex-
pression of transketolase (coded by tktA) and a feedback-
resistant (Fbr) DAHP synthase [coded by aroG(Fbr)] improves
the production of DAHP from glucose. However, the yields of
these processes are still far below the theoretical values.
To channel more carbon flux into the aromatic pathway, one
has to overcome pathways competing for PEP. PEP is also
used as a phosphate donor in the phosphotransferase system,
which is responsible for glucose uptake in E. coli. Moreover,
PEP can be converted to pyruvate by pyruvate kinases and to
oxaloacetate (OAA) by PEP carboxylase. Once PEP is con-
verted to pyruvate by either the phosphotransferase system or
pyruvate kinases, it is less likely to recycle back to PEP because
of the high energy cost. As a result, a large amount of carbon
flux is channelled through pyruvate and eventually to organic
acids, carbon dioxide, or cell mass. To overcome this stoichio-
metric limitation, we overexpressed PEP synthase (Pps) in the
presence of glucose and attempted to direct more carbon flux
into the aromatic pathway to produce DAHP.
MATERIALS AND METHODS
Strains and plasmids. E. coli AB2847 aroB mal T6r (20),
obtained from the E. coli Genetic Stock Center, Yale Univer-
sity, was used as the host strain for DAHP production. BJ502
tkt-2 flzuA22 garBlO ompF627 fadL701 reL41 pit-10 spoTl
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TABLE 1. Bacterial strains and plasmids used
Strain or plasmid Relevant genotype Source or reference
Strains
AB2847 aroB mal T6r E. coli Genetic Stock Center
BJ502 tkt-2 E. coli Genetic Stock Center
JC7623 recB21 recC22 sbcB15 26
HG4 pck-2 pps-3 Hughes Goldie
P0111734 araD139 ara::(Mu cts)3 A(lac)X74 galU galK rpsL with Mu dII1734 lac+(Kmr) 4
CAG12151 zdh-925::TnlO 22
JCL1242 A(argF-lac)U169 but ppc::Km 5
JCL1283 As for AB2847 but ppc::Km This study
JCL1362 As for AB2847 but pps::Mu dII1734 This study
Plasmids
pUHE23-2 Apr; IPTG-inducible T7(A1) early promoter H. Bujard
pPS341 As for pUHE23-2 but pps+ 18
pPS341X1 As for pPS341 but pps-50 (2-codon insertion) 18
pPS1734 pPS341::Mu dII1734 lac+(Kmr) This study
pRW5 pACYC184 derivative, Cmr but tandem lac promoters aroG(Fbr)+ Alan Berry
pAT1 As for pRW5 but tktA+ This study
mcrBl phoM510, also from the E. coli Genetic Stock Center,
was used in the identification of the tkt clone. JCL1242
ppc::Km was constructed as described previously (5) by insert-
ing a kanamycin cassette into a cloned ppc gene, which is then
integrated into the chromosome by homologous recombina-
tion.
Plasmid pPS341 was constructed as described previously
(18) by cloning a fragment of E. coli chromosomal DNA con-
taining the pps gene into an isopropyl-,3-D-thiogalactopyrano-
side (IPTG)-inducible expression vector, pUHE23-2 (a pBR322
derivative). Plasmid pPS341X1 containing the inactive gene
product ofpps was constructed by codon insertion mutagene-
sis, the details of which are also described by Patnaik et al. (18).
The pps gene on pPS341 was inserted with a Mu dII1734 lac+
Kmr (MudK) according to published protocol (4). Briefly, a
Mu lysate was made from donor strain POI11734/pPS341,
which was lysogenized by the mini-Mu element and a Mu cts.
The lysate was used to infect a Mu lysogen of HG4ppspck, and
colonies were selected for Apr and Kmr simultaneously to
ensure that the mini-Mu element hopped to the plasmid.
Colonies were further screened for the Pps- phenotype (in-
ability to grow on pyruvate). Restriction analysis of plasmid
DNA further confirmed the insertion of the MudK element
into the pps gene on plasmid pPS341. Twenty percent of these
selected colonies showed IPTG-dependent expression of 3-ga-
lactosidase, indicating an in-frame insertion. The plasmid from
one such colony is named pPS1734; it was linearized at the
ScaI site and then transformed into strain JC7623 recB21
recC22 sbcB15 (26). Transformants were sefected for Kmr and
scored for Ap sensitivity. Such colonies presumably contained
pps::MudK on the chromosome. By means of P1 transduction,
this locus was moved to AB2847, and Kmr transductants were
further screened for the inability to grow on pyruvate. One
such colony was designated JCL1362 and used for later studies.
The MudK insertion into chromosomal pps was further con-
firmed by cotransduction frequency (89%) with Tetr markers
from strain CAG12151 zdh-925::TnlO (22).
Plasmid pRW5, a kind gift of A. Berry of Genencor Inter-
national, South San Francisco, Calif., is a pACYC derivative
and contains aroG(Fbr). This plasmid also contains a lacI gene,
and aroG(Fbr) is expressed from a lac promoter. To construct
plasmid pAT1 containing both aroG(Fbr) and tktA, a 5-kb
BamHI fragment of E. coli DNA was cut from phage 473 of the
Kohara miniset (thanks to Yuji Kohara of the National
Institute of Genetics, Japan) and was inserted into the BamHI
site of pRW5. This fragment was reported to contain the tktA
gene (23), which was confirmed by its ability to complement a
tkt strain (BJ502) for growth on ribose and also by the
migration distance of the gene product on a sodium dodecyl
sulfate-12% polyacrylamide gel (molecular weight, ca. 72,500
[7]). The strains and plasmids used are summarized in Table 1.
Media and growth conditions. All cloning procedures were
carried out in Luria-Bertani medium. Yeast extract (YE)
medium (7) contained (per liter) K2HPO4 (14 g), KH2P04 (16
g), (NH4)2SO4 (5 g), MgSO4 (1 g), yeast extract (15 g), and
D-glucose (15 g). Minimal medium used for high-cell-density
resuspension cultures contained, per liter, K2HPO4 (14 g),
KH2PO4 (16 g), (NH4)2SO4 (5 g), MgSO4 (1 g), and D-glucose
(15 g) and was also supplemented with thiamine (1 mg),
shikimic acid (50 mg), L-tyrosine (8 mg), L-phenylalanine (8
mg), and L-tryptophan (4 mg). The minimal medium was
supplemented with succinate (0.1 g/liter) when the ppc mutant
and its control were grown. For the stable maintenance of
plasmids, ampicillin (100 mg/ml) and chloramphenicol (50
mg/ml) were added to the culture medium. The concentrations
of the antibiotics were reduced by half when minimal medium
was used.
Overnight cultures in YE medium were grown at 37°C in a
roller drum and then were subcultured in the same medium
with appropriate drugs. Cultures were grown in 250-ml shake
flasks at 37°C in a gyratory water bath shaken at 200 rpm. After
4 h of incubation (optical density at 550 nm, 2 to 3), cultures
were induced with IPTG (1 mM). Cells were harvested from
late stationary phase by centrifugation at 6,000 x g and were
washed twice with minimal medium before being resuspended
in the same minimal medium supplemented with appropriate
drugs and IPTG (1 mM). The initial optical densities at 550 nm
of all high-density resuspension cultures were about 4.0. Sam-
ples from the resuspension cultures were withdrawn periodi-
cally for assaying the DAH(P) and glucose concentrations in
the medium.
Determination of glucose and DAH(P). Cells were removed
from samples by centrifugation and the supernatants were
stored at 4°C until all samples had been collected. The level of
residual glucose in the culture supernatant was determined by
the dinitrosalicylic acid assay for total reducing sugars (16, 18).
The concentration of DAH(P) in the supernatant was deter-
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mined by the thiobarbiturate assay (7, 10). This assay does not
distinguish between DAH and DAHP.
Enzyme assays. Cells were harvested by centrifugation at
6,000 x g and were washed and resuspended in 50 mM
potassium phosphate buffer (pH 7) or 5 mM Tris-Cl-1 mM
MgCl2 (pH 7.4) for a DAHP synthase or Pps assay, respec-
tively. Cell extracts were prepared by rupturing cells with a
French pressure cell (SLM Aminco, Urbana, Ill.) at 16,000
lb/in2. DAHP synthase activity was assayed by the procedure of
Schoner and Herrmann (21). Pps activity was assayed as
described previously (18). Total protein in the extracts was
determined with the Bio-Rad dye reagent (Bradford assay)
and with bovine serum albumin as the standard.
RESULTS
Overexpression of Pps increases the production of DAHP.
AB2847 is unable to utilize DAHP and accumulates DAHP in
the medium if DAHP synthase is overexpressed. This strain
was used as a host for detecting the flux committed to the
aromatic pathways. Since Draths et al. (7) have shown a
possible limitation of E4P in the production of DAHP, we
transformed pAT1 [containing both aroG(Fbr) and tktA] into
AB2847 to eliminate the limitation of E4P. To test whether
PEP supply is also limiting in the production of DAHP, we
overexpressed Pps in AB2847/pAT1 by transforming plasmid
pPS341 into this strain. As a control, we replaced pPS341 with
pPS341X1 (18), which encodes an inactive but stable pps gene
product. The use of the inactive Pps control allows one to dis-
tinguish between the effect of Pps activity and that of protein
overexpression. We also used AB2847/pAT1/pUHE23-2 and
AB2847/pAT1 without any other plasmid as additional con-
trols to identify the effect of the cloning vector, pUHE23-2, on
DAHP production.
As described above, the strains were grown in a rich medium
(YE) with IPTG and resuspended in a minimal medium. Since
the overexpression of Pps under glycolytic conditions may
cause growth inhibition (18), resuspension cultures were used
to minimize the effect of cell growth on the biocatalytic
conversion. After resuspension, the excreted DAHP and resid-
ual glucose were measured periodically. At 27 h after resus-
pension, samples were taken for Pps and AroG assays. Fig. 1A
shows that the strain overexpressing active Pps increased
DAHP production almost twofold. The strains containing
pPS341X1 or pUHE23-2 produced the same amount of DAHP
as the one containing only pAT1. Figure 1B shows that, as
expected, Pps activity in the strain containing pPS341 is
overexpressed 10-fold, whereas the AroG activity in all strains
remains almost constant. These data strongly suggest that the
activity of Pps is responsible for the increase in DAHP
production, whereas the inactive Pps or the cloning vector has
no observable effect on DAHP production.
The specific glucose consumption rates of these strains were
not influenced by the presence of active or inactive Pps or by
the cloning vector (data not shown). Therefore, the strain
overexpressing Pps showed an almost twofold increase in
overall DAHP yield (ca. 90% molar yield) compared with
those of the controls (ca. 52% molar yield), suggesting that Pps
improves both the productivity and the yield of DAHP pro-
duction. The maximum theoretical yield from glucose to
DAHP is 86% (discussed below), which is slightly lower than
the measured yield from the strain overexpressing Pps. Be-
cause both glucose and DAHP measurements were reasonably
reproducible, the discrepancy may be attributed to the inaccu-
racy of the extinction coefficient (24) used to calculate DAHP
concentration. However, we have calibrated the extinction
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FIG. 1. Overexpression of Pps increased the production of DAHP.
The host strain was AB2847, and the plasmids were as labeled in the
figure. Note that pPSX1 and pUHE stand for pPS341X1 and
pUHE23-2, respectively. These strains were cultured first in YE
medium (a rich medium) to late stationary phase and then washed and
resuspended in a minimal medium (see the text). (A) DAHP concen-
trations measured at 10 and 27 h after resuspension; (B) activities of
DAHP synthase (AroG, 10-1) and PEP synthase (Pps) measured at 27
h after resuspension.
coefficient by using biosynthesized DAHP from cell extract and
known amounts of E4P and PEP. Results show that the
extinction coefficient is roughly within 30% accuracy. There-
fore, the yield of DAHP is reasonably close to the theoretical
maximum, even though it may be lower than the theoretical
value.
To determine whether the Pps effect requires overexpressed
Tkt, we used plasmid pRW5, which contains only aroG(Fbr),
to replace pAT1 in the experiments described above. We
found that overproduction of Pps did not increase DAHP
production (Fig. 2A) without the elevated Tkt activity. There-
fore, so far as limitation of small molecules in the biosynthesis
of DAHP is concerned, the first limitation arises from the
supply of E4P. This bottleneck shifts to the supply of PEP
when Tkt is overexpressed, which is believed to increase the
supply of E4P.
Chromosomal null mutations of pps and ppc. As shown
above, Pps overexpression improved DAHP production from
glucose. It was interesting to know whether the basal level of
Pps expression in glucose medium contributed to the produc-
tion of DAHP. We therefore knocked out the chromosomal
pps gene in strain AB2847. The resulting strain (JCL1362) was
used as the host to repeat the above-described experiments.
Results show that inactivation of chromosomal pps did not
significantly affect DAHP production in strains containing
pRW5 or pAT1 (Fig. 2B). Therefore, the basal level of pps
expression in glucose medium did not contribute to DAHP
production.
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FIG. 2. DAHP production at 10 and 27 h after resuspension. (A)
Strain AB2847 with the plasmids shown below the x axis. pPSX1 and
pUHE stand for pPS341X1 and pUHE23-2, respectively. (B) Strains
AB2847 (AB), JCL1283ppc::Km (ppc), and JCL1362pps::MudK (pps)
with the plasmids shown below the x axis.
Since PEP is also converted to OAA by Ppc, the deletion of
this enzyme may increase the supply of PEP. We therefore
inactivated the ppc gene on the chromosome of AB2847 in
an attempt to increase DAHP production without Pps overex-
pression. This was done by transducing AB2847 with a P1
lysate grown on JCL1242ppc::Km. The resulting transductant,
JCL1283 aroB ppc::Km, was then transformed with pAT1 or
pRW5 and tested for DAHP production in the resuspension
culture as described above. To avoid limitation of OAA in the
ppc strain, the culture medium was supplemented with succi-
nate, which was shown to have no effect on DAHP production
(data not shown). Contrary to the expectation, the ppc muta-
tion did not increase the production of DAHP (Fig. 2B),
suggesting that the metabolic flux from PEP to OAA was not
significant under the experimental conditions tested here. In
fact, the ppc mutation actually decreased DAHP production
for unknown reasons.
DISCUSSION
According to theoretical analyses (9, 13), the maximum yield
of aromatic amino acids from glucose can be increased twofold
if pyruvate is recycled back to PEP. The maximum yield is
calculated by assuming that the branching pathways are
blocked and that the carbon flow is directed by the most
efficient pathways with minimum loss to carbon dioxide and
other metabolites. Under these conditions, the relative flux
through each step at the steady state can be calculated by
balancing the input and output fluxes from each metabolite
(A)
IAroG
DAHP
FIG. 3. Reaction pathways for maximal conversion of glucose to
DAHP for strains without Pps (A) and strains overexpressing Pps (B).
The numbers are the relative fluxes needed to convert 7 mol of glucose
to DAHP. G6P, glucose 6-P; F6P, fructose 6-P; 1,6FDP, 1,6-fructose
diphosphate; DHAP, dihydroxyacetone phosphate; GAP, glyceralde-
hyde 3-P, R5P, ribose 5-P; X5P, xylulose 5-P; S7P, sedoheptulose 7-P;
PYR, pyruvate.
pool. As shown in Fig. 3A, for maximum yield of DAHP
production by strains without Pps overproduction, 7 mol of
glucose is needed to produce 3 mol of DAHP (43% molar
yield) and 7 mol of pyruvate, which is further metabolized. The
relative flux through each intermediate step is shown in Fig.
3A. The formation of pyruvate is necessary because of the
stoichiometry of the phosphotransferase system for glucose
uptake. In the presence of glucose, pyruvate is not recycled
back to PEP efficiently because the enzyme Pps is not induced.
However, if pyruvate is effectively recycled to PEP via overex-
pressed Pps in the presence of glucose, the maximum yield will
increase twofold, reaching the theoretical level. As shown in
Fig. 3B, 6 mol of DAHP can now be produced from 7 mol of
glucose (86% molar yield). The nonoxidative part of the
pentose pathway provides E4P, and the Pps reaction recycles
pyruvate to PEP.
The data shown above are in agreement with this flux
distribution model. Although it is difficult to measure flux
mediated by Pps directly, the controls with inactive Pps and
a-
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with no Pps demonstrate that the activity of Pps is required to
achieve this high yield. Unfortunately, measurements of intra-
cellular PEP are difficult because of its small quantity and high
turnover rate. According to Lowry et al. (14), the PEP con-
centration is below 0.5 j±mollg (dry weight) with about 50%
standard deviations. In our hands, the measurement was not
sensitive enough to detect the change in PEP level due to Pps
overproduction, particularly because PEP is further converted
to DAHP by overexpressed DAHP synthase. The observation
that the Pps effect on DAHP production requires the overex-
pressed Tkt suggests that E4P is the first limiting substrate for
DAHP synthase. Therefore, without a sufficient supply of E4P,
increasing the flux to PEP with Pps does not lead to increased
DAHP production. However, supplying E4P alone by Tkt
overexpression cannot increase the yield to near the theoreti-
cal level (Fig. 2A) because of the stoichiometric limitation in
pyruvate recycling to PEP (Fig. 3A).
In our previous work (18), we demonstrated that overexpres-
sion of Pps in the presence of glucose led to growth inhibition,
increased glucose consumption, and excretion of pyruvate and
acetate. To overcome the problem of growth impairment, we
had to use high-density resuspension cultures which have high
levels of metabolic activity but very low growth rates. In
actively growing cultures, the effects of Pps on DAHP produc-
tion are not as significant and the impairment of growth caused
by Pps overexpression negates the positive effects on DAHP
production. The stimulation of glucose consumption in the
previous work was attributed to the altered PEP/pyruvate
ratio. It was hypothesized that an increased PEP/pyruvate ratio
stimulates the phosphotransferase system for increased glu-
cose consumption, which in turn results in the excretion of
pyruvate. In the present study, we redirected PEP to the
aromatic pathway, and thus the PEP/pyruvate ratio is likely to
decrease. This flux redirection explains the insensitivity of the
specific glucose consumption rate to Pps overexpression in the
experimental system used in this study. The increased DAHP
production from glucose caused by Pps overexpression also
suggests that Pps actually functions in its physiological direc-
tion (from pyruvate to PEP) in vivo, even under glycolytic
conditions.
It has been reported that the deletion of ppc increased the
production of phenylalanine and acetate (17). Moreover, our
group has shown that the overexpression of Ppc in a wild-type
host reduces acetate production (5). Both results suggest that
the flux through Ppc (from PEP to OAA) is reasonably
significant under those conditions, and thus, the modulation of
Ppc expression level affects the utilization of PEP. In the
present work, however, we did not observe any positive effect
on DAHP production by deleting the chromosomal ppc gene,
suggesting that the flux through Ppc is not important under the
experimental conditions used here. The discrepancy may be
attributed to the nongrowth condition used in our experiment
and to the phenotypical variation in the host strains. Note that
the reaction scheme for theoretical yield (Fig. 3B) does not
require pyruvate kinases or the oxidative part of the pentose
pathway. Therefore, it is possible that the inactivation of
pyruvate kinases or the glucose 6-P dehydrogenase during the
production phase may ensure the high yield of DAHP.
This work demonstrates that engineering the central metab-
olism according to the stoichiometric analysis can lead to
improvements in both the productivity and yield. However,
such analysis is predicated on the assumptions that the all the
reaction steps are known and that the physiological role of
each step in vivo is also known under the conditions of interest.
Despite the extensive research on E. coli metabolism, it is still
possible that unknown physiological roles of existing enzymes
or new reactions exist, which may invalidate the stoichiometric
analysis.
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